UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION

12 Months Ended

Dec. 31, 2016

Quarterly Financial Information [Abstract]

UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION

16. UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION
						Net Income (Loss) Attributable to Amedisys, Inc. Common Stockholders (1)
		Revenue		Net Income (Loss) Attributable to Amedisys, Inc.		Basic		Diluted
	2016:
	1st Quarter (2) (3) (4)	$	348.8	$	6.2	$	0.19	$	0.19
	2nd Quarter (2) (3) (4)		360.7		10.7		0.32		0.32
	3rd Quarter (2) (3) (4)		361.6		11.4		0.34		0.34
	4th Quarter (2) (3) (4) (5)		366.3		8.9		0.27		0.26
		$	1,437.4	$	37.3	$	1.12	$	1.10
	2015:
	1st Quarter (6) (7)	$	301.6	$	(35.0)	$	(1.07)	$	(1.07)
	2nd Quarter (7)		314.1		10.6		0.32		0.32
	3rd Quarter (6) (7) (9)		326.4		8.4		0.25		0.25
	4th Quarter (7) (8) (9)		338.4		12.9		0.39		0.38
		$	1,280.5	$	3.0	$	(0.09)	$	(0.09)

• Because of the method used in calculating per share data, the quarterly per share data may not necessarily total to the per share data as computed for the entire year.
• During each of the four quarters of 2016, we incurred certain costs associated with the implementation of Homecare Homebase. Net of income taxes, these costs amounted to $1.5 million, $1.6 million, $1.2 million and $0.8 million for the three-month periods ended March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016, respectively.
• During each of the four quarters of 2016, we incurred certain costs associated with various legal matters. Net of income taxes, these costs amounted to $0.9 million, $0.3 million, $0.2 million and $1.8 million for the three-month periods ended March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016, respectively.
• During each of the four quarters of 2016, we incurred certain costs associated with various acquisition costs. Net of income taxes, these costs amounted to $1.0 million, $0.2 million, $0.3 million and $0.5 million for the three-month periods ended March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016, respectively.
• During the fourth quarter of 2016, we recorded a non-cash asset impairment charge to write-off assets as a result of our conversion from our proprietary operating system to Homecare Homebase in the amount of $2.7 million, net of income taxes.
• During the first quarter of 2015, we recorded a non-cash asset impairment charge to write-off the software costs incurred related to the development of AMS3 Home Health and Hospice in the amount of $45.5 million, net of income taxes. During the third quarter of 2015, we recorded a non-cash asset impairment charge related to our corporate headquarters in the amount of $1.2 million, net of income taxes.
• During each of the four quarters of 2015, we incurred certain costs associated with various legal matters. Net of income taxes, these costs amounted to $1.3 million, $4.8 million, $0.2 million and $(1.1) million for the three-month periods ended March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, respectively.
• During the fourth quarter of 2015, we recorded an accrual related to an OIG Self-Disclosure matter. Net of income taxes, this charge amounted to $3.4 million.
• During the third and fourth quarters of 2015, we incurred certain costs associated with the implementation of Homecare Homebase. Net of income taxes, these costs amounted to $1.2 million and $1.4 million for the three-month periods ended September 30, 2015 and December 31, 2015, respectively.